Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data-Reference-Cited by-同舟云学术

Rapid Metabolism Underlying Subtherapeutic Serum Levels of Atypical Antipsychotics Preceding Clozapine Treatment: A Retrospective Analysis of Real-World Data

Published:2024-04-18 Issue:6 Volume:38 Page:473-480
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Lenk Hasan Çağın^ORCID,Smith Robert Løvsletten^ORCID,O’Connell Kevin S.^ORCID,Andreassen Ole A.^ORCID,Molden Espen^ORCID

Funder

Helse Sør-Øst RHF

Horizon 2020

University of Oslo

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40263-024-01079-y.pdf

Reference27 articles.

1. Howes OD, McCutcheon R, Agid O, de Bartolomeis A, van Beveren NJM, Birnbaum ML, et al. Treatment resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 2017;174:216–29. https://doi.org/10.1176/appi.ajp.2016.16050503.

2. Siskind D, Orr S, Sinha S, Yu O, Brijball B, Warren N, et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry. 2022;220:115–20. https://doi.org/10.1192/bjp.2021.61.

3. Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394:939–51. https://doi.org/10.1016/S0140-6736(19)31135-3.

4. Miller DD. Review and management of clozapine side effects. J Clin Psychiatry. 2000;61(Suppl 8):14–7.

5. Howes OD, Thase ME, Pillinger T. Treatment resistance in psychiatry: state of the art and new directions. Mol Psychiatry. 2022;27:58–72. https://doi.org/10.1038/s41380-021-01200-3.